SeaStar Medical is trading 6.4% lower at $3.36, with no identified company-specific announcement or confirmed catalyst explaining the October 14, 2026 decline. - Shares also fell 6.75% in the October 13 session, according to reported coverage. - The FDA breakthrough-device designation announced October 7, plus other recent updates, predates the decline and does not clearly explain it. - Healthcare is higher and major indexes are mixed; evidence does not establish a sector or broad-market cause.